Advertisement

Topics

Avila Therapeutics, Inc. & Clovis Oncology, Inc. Company Profile

07:07 EDT 23rd September 2017 | BioPortfolio


News Articles [2814 Associated News Articles listed on BioPortfolio]

BMS, Clovis to collaborate on cancer studies

Bristol-Myers Squibb and Clovis Oncology agreed to combine the former's Opdivo, or nivolumab, and Clovis' Rubraca, or rucapar -More- 

Clovis Oncology to Announce Second Quarter 2017 Financial Results and Host Webcast Conference ...

Clovis Oncology, Inc.Breanna Burkart, 303-625-5023bburkart@clovisoncology.comorAnna Sussman, 303-625-5022asussman@clovisoncology.com Read more...

Bristol-Myers Squibb and Clovis Oncology announce a broad clinical collaboration

Bristol-Myers Squibb Company (NYSE:BMY) and Clovis Oncology, Inc. (Nasdaq:CLVS) announced the companies have entered into a clinical collaboration agreement to evaluate the combination of Bristol-Myer...

Clovis Oncology to Announce Second Quarter 2017 Financial Results and Host Webcast Conference Call on August 2

Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its second quarter 2017 financial results on Wednesday, August 2, 2017, after the close of the U.S. financial markets. Clovis’...

The biotech mailbag: Your questions answered on Clovis Oncology, CytRx, Brainstorm Therapeutics, and more

Columnist Adam Feuerstein answers your question on biotech stocks and clinical trials in oncology, ALS, iron replacement therapy, and more.

Clovis Pops on Bristol-Myers Partnership; Intercept Dives on Weak Earnings: Biotech Movers

Shares of Clovis Oncology Inc. were down 7.4% to $90.80 in premarket trading on Monday, July 31. The Boulder, Colo.-based firm and Bristol-Myers Squibb Co. unveiled a collaboration to evaluate the com...

Clovis Oncology's Rubraca data sets stage for label expansion

(Reuters) - Positive data on Clovis Oncology Inc's ovarian cancer drug, Rubraca, from a late-stage study could help the U.S. biotech widen the use of the therapy and differentiate it against rivals, t...

Clovis Oncology's cancer drug Rubraca succeeds in key study

(Reuters) - Clovis Oncology Inc said its ovarian cancer drug Rubraca slowed disease progression in a late-stage trial involving patients with various gene mutations who had undergone initial therapy....

PubMed Articles [2261 Associated PubMed Articles listed on BioPortfolio]

New Designs for Basket Clinical Trials in Oncology.

The established molecular heterogeneity of human cancers has had profound effects on the design of cancer therapeutics. Most cancer drugs are today targeted to molecular alterations present in cancer ...

Tracing social interactions in Pleistocene North America via 3D model analysis of stone tool asymmetry.

Stone tools, often the sole remnant of prehistoric hunter-gatherer behavior, are frequently used as evidence of ancient human mobility, resource use, and environmental adaptation. In North America, st...

Checkpoint inhibitors: a cutting edge in oncology.

The checkpoint inhibitor field, and indeed the whole of immuno-oncology, is fast-paced and fascinating, with huge clinical and commercial potential. The challenge in the coming years will be to define...

Hematology-Oncology Fellows' Training in Geriatrics and Geriatric Oncology: Findings From an American Society of Clinical Oncology-Sponsored National Survey.

Older adults compose the majority of patients with cancer in the United States; however, it is unclear how well geriatrics or geriatric oncology training is being incorporated into hematology-oncology...

Immune oncology and neuroendocrine tumors.

Clinical Trials [507 Associated Clinical Trials listed on BioPortfolio]

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best che...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Support of the Sexual Health in Oncology

Implementation of sexual health support program in oncology department. This program is organized in 3 axes. One is to inform the side effects of treatment on sexual health. There is a co...

Osteopathic Manipulative Treatment in Oncology Patients' Management

The aim of present study was to study the osteopathic manipulative effects on pain relief and quality of life improvement on hospitalized oncology geriatric patients. A non-randomized comp...

Companies [1756 Associated Companies listed on BioPortfolio]

Clovis Oncology, Inc.

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis...

Avila Therapeutics, Inc.

Avila focuses on design and development of targeted covalent drugs to achieve best-in-class outcomes that cannot be achieved through traditional chemistries. This approach is call...

Cecilia Ferradino & Diana de Avila

The Med Ready Puffer Tote was invented by Diana de Avila and Cecilia Ferradino as a simple solution to carrying asthma inhalers. Cecilia is a doctoral student and Diana, who has MS, is retired. They o...

Maverick Therapeutics Inc.

Maverick Therapeutics is pioneering the next generation of redirected T cell therapeutics in immuno-oncology. Maverick’s highly innovative platform is designed to deliver pot...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "Avila Therapeutics, Inc. & Clovis Oncology, Inc." on BioPortfolio

We have published hundreds of Avila Therapeutics, Inc. & Clovis Oncology, Inc. news stories on BioPortfolio along with dozens of Avila Therapeutics, Inc. & Clovis Oncology, Inc. Clinical Trials and PubMed Articles about Avila Therapeutics, Inc. & Clovis Oncology, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Avila Therapeutics, Inc. & Clovis Oncology, Inc. Companies in our database. You can also find out about relevant Avila Therapeutics, Inc. & Clovis Oncology, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record